-
Onglyza gets label update
PRINCETON, N.J., and WILMINGTON, Del. — The makers behind a popular Type 2 diabetes treatment have included data from two clinical studies in an update to the drug's prescribing information.
Bristol-Myers Squibb and AstraZeneca said the Food and Drug Administration approved the labeling update for Onglyza (saxagliptin), which now includes efficacy and safety information about the drug's effects on patients with renal impairment or end-stage renal disease.
-
Report: North Dakota pharmacy ownership bill defeated
NORTH DAKOTA — A House bill that would have paved the path for chain and big-box pharmacy retailers to set up shop in North Dakota was rejected on Tuesday, according to a local news report.
Under the current law, pharmacies must be majority-owned by a licensed pharmacist, but House Bill 1434 would have eliminated that portion of the law, the Bismarck Tribune reported. The bill was defeated 71-23.
Those in favor of the bill said the state should open up the market to competition.